Clinical Trial: A Study Comparing the Effectiveness and Safety of Cenobamate When Used as the First Add-On Medication or Added After Other Medications in People with Focal Epilepsy (China)

Posted On: 2026-09-22

China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study Comparing the Effectiveness and Safety of Cenobamate When Used as the First Add-On Medication or Added After Other Medications in People with Focal Epilepsy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133058

Registration Time: 2026/09/21

Type: Observational study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343659

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Study Comparing the Effectiveness and Safety of Cenobamate When Used as the First Add-On Medication or Added After Other Medications in People with Focal Epilepsy (China)